THE EFFECTS OF L-DOPA ON EXCESSIVE DAYTIME SLEEPINESS IN NARCOLEPSY

被引:40
作者
BOIVIN, DB [1 ]
MONTPLAISIR, J [1 ]
机构
[1] HOP SACRE COEUR, CTR SLEEP DISORDERS, 5400 BLVD GOUIN OUEST, MONTREAL H4J 1C5, QUEBEC, CANADA
关键词
D O I
10.1212/WNL.41.8.1267
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We examined the effects of L-dopa on the excessive daytime sleepiness of six narcoleptic patients while using a double-blind design and objective measurements of vigilance. The two treatment periods, L-dopa or placebo, lasted for 2 weeks each, separated by a 1-week washout period. In addition to the standard Multiple Sleep Latency Test (MSLT), two different tests assessed the daytime vigilance: the Analogue Vigilance Scale (AVS) and the Four Choice Reaction Time Test (FCRTT). L-dopa improved vigilance and performance as evaluated by the AVS and the FCRTT, while the capacity to fall asleep rapidly remained unchanged as evaluated by the MSLT. Results of the present study suggest that L-dopa is effective in improving the vigilance level of narcoleptic patients and raises the hypothesis that dopamine may play a role in the physiopathology of excessive daytime sleepiness of this condition.
引用
收藏
页码:1267 / 1269
页数:3
相关论文
共 40 条
  • [11] DEMENT WC, 1976, NARCOLEPSY, V2, P17
  • [12] L-DOPA - EFFECT ON CONCENTRATIONS OF DOPAMINE, NOREPINEPHRINE, AND SEROTONIN IN BRAINS OF MICE
    EVERETT, GM
    BORCHERDING, JW
    [J]. SCIENCE, 1970, 168 (3933) : 849 - +
  • [13] CEREBROSPINAL-FLUID MONOAMINE METABOLITES IN NARCOLEPSY AND HYPERSOMNIA
    FAULL, KF
    GUILLEMINAULT, C
    BERGER, PA
    BARCHAS, JD
    [J]. ANNALS OF NEUROLOGY, 1983, 13 (03) : 258 - 263
  • [14] GROVES PM, 1983, STIMULANTS NEUROCHEM, P81
  • [15] VILOXAZINE HYDROCHLORIDE IN NARCOLEPSY - A PRELIMINARY-REPORT
    GUILLEMINAULT, C
    MANCUSO, J
    SALVA, MAQ
    HAYES, B
    MITLER, M
    POIRIER, G
    MONTPLAISIR, J
    [J]. SLEEP, 1986, 9 (01) : 275 - 279
  • [16] GUILLEMINAULT C, 1972, SLEEP RES, V1, P150
  • [17] PRELIMINARY CLINICAL TRIAL WITH L-DOPA IN NARCOLEPSY
    GUNNE, LM
    LIDVALL, HF
    WIDEN, L
    [J]. PSYCHOPHARMACOLOGIA, 1971, 19 (02): : 204 - &
  • [18] HALARIS AE, 1975, BIOLOGY MAJOR PSYCHO, V54, P247
  • [19] Hardie RJ, 1990, PARKINSON DISEASE, P559
  • [20] MULTIPLE DOPAMINE-RECEPTORS AND BEHAVIOR
    JOYCE, JN
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1983, 7 (02) : 227 - 256